An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies

@article{Iffland2017AnUO,
  title={An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies},
  author={Kerstin Iffland and F. Grotenhermen},
  journal={Cannabis and Cannabinoid Research},
  year={2017},
  volume={2},
  pages={139 - 154}
}
Abstract Introduction: This literature survey aims to extend the comprehensive survey performed by Bergamaschi et al. in 2011 on cannabidiol (CBD) safety and side effects. Apart from updating the literature, this article focuses on clinical studies and CBD potential interactions with other drugs. Results: In general, the often described favorable safety profile of CBD in humans was confirmed and extended by the reviewed research. The majority of studies were performed for treatment of epilepsy… Expand
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials
Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 76 REFERENCES
A systematic review of the antipsychotic properties of cannabidiol in humans
Safety and side effects of cannabidiol, a Cannabis sativa constituent.
Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy
Molecular Targets of Cannabidiol in Neurological Disorders
Controlled clinical trial of cannabidiol in Huntington's disease
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.
  • S. Burstein
  • Chemistry, Medicine
  • Bioorganic & medicinal chemistry
  • 2015
Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
Cannabidiol for the treatment of psychosis in Parkinson’s disease
...
1
2
3
4
5
...